Delivery Order SPE2DB24D8002-SPE2DB25FJNBP
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $8,445.88, is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on March 18, 2025. The contract is a delivery order issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a total potential value of...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBPZE, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $16,771.40 Firm Fixed Price Delivery Order contract is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a performance period through November 7, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $9,456.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 18, 2024. This award is part of Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at $999,999,999.00, which allows the company to provide a comprehensive range of...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZLG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $8,114.16 and a period of performance through March 28, 2025. It is a Firm Fixed Price Delivery Order contract,...
This federal contract award, identified as SPE2DX15D8002|SPE2DX23F2XL4, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to the prime contractor Dakota Drug, Inc. The $8,963.87 firm fixed-price delivery order is for the procurement of STELARA 90 MG/ML syringes, a pharmaceutical product. The contract has a performance period extending through May 18, 2023 and is not a set-aside award. Dakota Drug, Inc. is a self-certified small disadvantaged business that...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYYJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract, valued at $10,413.85, is a firm-fixed-price delivery order for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical supplies,...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQKX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,091.23 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML pharmaceutical products. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, as part of the DLA Troop Support Medical's...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZBM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,352.56 firm fixed-price delivery order is for the provision of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $20,476.24 firm fixed-price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGEML, with a period of performance through February 27, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's...
The federal contract award SPE2DB24D8002|SPE2DB24FJMPZ was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,567.65 Firm Fixed Price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGEML, with a performance period ending on July 19, 2024. This contract is not a set-aside award. Dakota Drug, Inc. is an experienced federal contractor, holding a $999,999,999.00 Indefinite Delivery...